Literature DB >> 9405664

Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.

B y Wang1, N S El-Badri, R A Good.   

Abstract

We report herein the successful long term engraftment of highly purified hematopoietic stem cells (HSCs) without any facilitating cells in fully allogeneic recipient mice across the entire major histocompatibility complex (MHC) transplantation barrier. This finding challenges the assumption that highly purified marrow HSCs alone cannot produce long-lived allogeneic bone marrow chimeras across the MHC barrier. In the present experiments, 1 x 10(5) HSCs from 5-fluorouracil (5-FU)-treated donors, without any facilitating cells, have been found to repopulate lethally irradiated fully allogeneic recipients. Low density, lineage-negative (CD4-, CD8-, B220-, Mac-1-, Gr-1-), CD71-negative, class I highly positive, FACS-sorted cells from 5-FU-treated C57BL/6 (B6) donor mice were transplanted into lethally irradiated BALB/c recipients. (BALB/c --> BALB/c) --> BALB/c T cell-depleted marrow cells used as compromised cells were also transplanted into the recipients to permit experiments to be pursued over a long period of time. Cells of donor origin in all recognized lineages of hematopoietic cells developed in these allogeneic chimeras. One thousand HSCs were sufficient to repopulate hemiallogeneic recipients, but 1 x 10(4) HSCs alone from 5-FU-treated donors failed to repopulate the fully allogeneic recipients. Transplantation of primary marrow stromal cells or bones of the donor strain into recipient, together with 1 x 10(4) HSCs, also failed to reconstitute fully allogeneic recipients. Suppression of resistance of recipients by thymectomy or injections of granulocyte colony-stimulating factor before stem cell transplantation enhanced the engraftment of allogeneic HSCs. Our experiments show that reconstitution of all lymphohematopoietic lineages across the entire MHC transplantation barriers may be achieved by transplanting allogeneic HSCs alone, without any facilitating cells, as long as a sufficient number of HSCs is transplanted.

Entities:  

Mesh:

Year:  1997        PMID: 9405664      PMCID: PMC25076          DOI: 10.1073/pnas.94.26.14632

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Mouse hematopoietic stem cells.

Authors:  G J Spangrude; L Smith; N Uchida; K Ikuta; S Heimfeld; J Friedman; I L Weissman
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

2.  Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma.

Authors:  G J Ossenkoppele; A R Jonkhoff; P C Huijgens; J J Nauta; K G van der Hem; A M Dräger; M M Langenhuijsen
Journal:  Bone Marrow Transplant       Date:  1994-01       Impact factor: 5.483

Review 3.  Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).

Authors:  M Bregni; S Siena; G Bonadonna; A M Gianni
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

4.  Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

Authors:  R A Gatti; H J Meuwissen; H D Allen; R Hong; R A Good
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

5.  Pluripotent hemopoietic stem cells are c-kit<low.

Authors:  H Doi; M Inaba; Y Yamamoto; S Taketani; S I Mori; A Sugihara; H Ogata; J Toki; H Hisha; K Inaba; S Sogo; M Adachi; T Matsuda; R A Good; S Ikehara
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Monoclonal antibody J11d.2 recognizes cell cycle-dormant, primitive hematopoietic progenitors of mice.

Authors:  J P Shih; M Ogawa
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

7.  Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells.

Authors:  D E Harrison; C M Astle; C Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  Lymphohemopoietic reconstitution using wheat germ agglutinin-positive hemopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers.

Authors:  N S el Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.

Authors:  T Suzue; Y Kawano; Y Takaue; Y Kuroda
Journal:  Exp Hematol       Date:  1994-08       Impact factor: 3.084

10.  Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells.

Authors:  R Snodgrass; G Keller
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  3 in total

1.  Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.

Authors:  Junke Zheng; Masato Umikawa; Shichuan Zhang; HoangDinh Huynh; Robert Silvany; Benjamin P C Chen; Lieping Chen; Cheng Cheng Zhang
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

2.  Hematopoietic colony-forming cells derived from human embryonic stem cells.

Authors:  D S Kaufman; E T Hanson; R L Lewis; R Auerbach; J A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

3.  Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.

Authors:  B Wang; Y Yamamoto; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.